TABLE 1.
Group | No Preinfusion | IPH | Preinfused | Experimental Phase* | ||||
---|---|---|---|---|---|---|---|---|
IPH | Total | T2 Map | T1 Enhancement | T1/T2 Volume | ||||
Controls | 57 | 4 | 8 | 0 | 65 | 65 | 52 | 15 |
VEGF (ng/hr) | ||||||||
Low-dose (2) | 80 | 5 | 8 | 0 | 88 | 88 | 45 | 15 |
Medium-dose (10) | 23 | 16 | 4 | 0 | 27 | — | — | — |
High-dose (20) | 2 | 2 | 0 | 0 | 2 | — | — | — |
Single injection (100 ng) | 3 | 0 | — | — | — | — | — | — |
MRI data was analyzed from images obtained from animal numbers listed in the 3 columns on the right.